Is Immunome stock halal?
Yes
Immunome passes our halal screen: its business is permitted and its debt is 0.2% of its market value, under the 30% limit, and its cash is 29%, under the 30% limit.
This result is close to a limit and can change as the share price moves.
Interest income is only checked on a reviewed list of companies, not for every stock.
The numbers behind it
How we decide
We follow AAOIFI Shariah Standard 21: the main business must be permitted, debt and cash must each stay under 30% of market value, and impermissible revenue under 5%. We also fail a stock when cash plus receivables reach 49%, as S&P's Shariah indices do. We count all cash because filings rarely split out deposits that earn interest, plus short-term investments confirmed as debt securities or deposits. Short-term investments whose type is not reported can make a stock questionable but not a fail. Firms that hold client money count plain cash only. We use the latest yearly balance sheet, and we can only see impermissible revenue that a company reports as a segment. This is a screen, not a fatwa. Ask a scholar you trust if you are unsure.
Purifying the dividend
Immunome pays no dividend, so there is nothing to purify from dividends.
Why another app may say something else
Screeners use different limits, measure debt against different things and read filings on different dates, so the same stock can pass on one and fail on another. Why halal screeners disagree explains each difference, and the numbers above let you check this one yourself.
More questions about Immunome
Data as of Nov 13, 2026.